ArticleBMC microbiology2025
Pilus-mediated co-aggregation with Lactobacillus crispatus increases meningococcal susceptibility to antimicrobial agents by interfering with microcolony formation.
Article in BMC microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Integrative analysis of the meibum microbiome in dry eye disease: from dysbiosis and diagnostic biomarkers to immunomodulation by Bradyrhizobium-derived outer membrane vesicles.Journal of translational medicine · 2026Article
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundNeisseria meningitidis asymptomatically colonizes the nasopharyngeal mucosa, but occasionally, the bacteria disseminate to cause sepsis and meningitis. In the epithelial cell layer, the pathogen co-colonizes with other resident inhabitants, such as Lactobacillus species that are part of the nasopharyngeal-oral microbiota. In this study, we investigated the interaction between lactobacilli and meningococci.
resultsWe demonstrated that Lactobacillus crispatus strain MV24 can co-aggregate with meningococci, whereas all other Lactobacillus strains tested did not co-aggregate. The binding ability of L. crispatus was not strain- or serogroup-specific but was dependent on the ability of meningococci to form microcolonies. The finding that N. meningitidis lacking pili did not co-aggregate with L. crispatus, but that hyperpiliated N. meningitidis exhibited strong co-aggregation, led us to examine the interaction between purified meningococcal pili and lactobacilli. Our results showed that L. crispatus MV24 can bind to purified meningococcal Class I and II pili, explaining the aggregative clusters observed under the microscope. Co-aggregation with L. crispatus disrupted microcolony formation, and increased the killing of meningococci by LL-37, hBD2 and cephalexin. Further, co-aggregation had the added effect of impeding motility.
conclusionN. meningitidis pili bind to L. crispatus, which interferes with the meningococcal microcolonies and increases sensitivity to antimicrobial agents. Taken together, our findings suggest that L. crispatus MV24 may have a beneficial effect on the host through co-aggregating with meningococci.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.